INTRODUCTION: Biallelic mutations in STUB1, which encodes the E3 ubiquitin ligase CHIP, were originally described in association with SCAR16, a rare autosomal recessive spinocerebellar ataxia, so far reported in 16 kindreds. In the last 2 years, a new form of spinocerebellar ataxia (SCA48), associated with heterozygous mutations in the same gene, has been described in 12 kindreds with autosomal dominant inheritance. METHODS: We reviewed molecular and clinical findings of both SCAR16 and SCA48 described patients. RESULTS AND CONCLUSION: SCAR16 is characterized by early onset spastic ataxia and a wide disease spectrum, including cognitive dysfunction, hyperkinetic disorders, epilepsy, peripheral neuropathy, and hypogonadism. SCA48 is an adult-onset syndrome characterized by ataxia and cognitive-psychiatric features, variably associated with chorea, parkinsonism, dystonia, and urinary symptoms. SCA48, the last dominant ataxia to be described, could emerge as the most frequent among the SCAs due to conventional mutations. The overlap of several clinical signs between SCAR16 and SCA48 indicates the presence of a continuous clinical spectrum among recessively and dominantly inherited mutations of STUB1. Different kinds of mutations, scattered over the three gene domains, have been found in both disorders. Their pathogenesis and the relationship between SCA48 and SCAR16 remain to be clarified.
INTRODUCTION: Biallelic mutations in STUB1, which encodes the E3 ubiquitin ligase CHIP, were originally described in association with SCAR16, a rare autosomal recessive spinocerebellar ataxia, so far reported in 16 kindreds. In the last 2 years, a new form of spinocerebellar ataxia (SCA48), associated with heterozygous mutations in the same gene, has been described in 12 kindreds with autosomal dominant inheritance. METHODS: We reviewed molecular and clinical findings of both SCAR16 and SCA48 described patients. RESULTS AND CONCLUSION:SCAR16 is characterized by early onset spastic ataxia and a wide disease spectrum, including cognitive dysfunction, hyperkinetic disorders, epilepsy, peripheral neuropathy, and hypogonadism. SCA48 is an adult-onset syndrome characterized by ataxia and cognitive-psychiatric features, variably associated with chorea, parkinsonism, dystonia, and urinary symptoms. SCA48, the last dominant ataxia to be described, could emerge as the most frequent among the SCAs due to conventional mutations. The overlap of several clinical signs between SCAR16 and SCA48 indicates the presence of a continuous clinical spectrum among recessively and dominantly inherited mutations of STUB1. Different kinds of mutations, scattered over the three gene domains, have been found in both disorders. Their pathogenesis and the relationship between SCA48 and SCAR16 remain to be clarified.
Authors: R Palvadeau; Z E Kaya-Güleç; G Şimşir; A Vural; Ö Öztop-Çakmak; G Genç; M S Aygün; O Falay; A Nazlı Başak; S Ertan Journal: Neurogenetics Date: 2019-11-19 Impact factor: 2.660
Authors: Ketil Heimdal; Monica Sanchez-Guixé; Ingvild Aukrust; Jens Bollerslev; Ove Bruland; Greg Eigner Jablonski; Anne Kjersti Erichsen; Einar Gude; Jeanette A Koht; Sigrid Erdal; Torunn Fiskerstrand; Bjørn Ivar Haukanes; Helge Boman; Lise Bjørkhaug; Chantal M E Tallaksen; Per M Knappskog; Stefan Johansson Journal: Orphanet J Rare Dis Date: 2014-09-26 Impact factor: 4.123
Authors: Adam J Kanack; Michael D Olp; Oliver J Newsom; Jamie B Scaglione; David M Gooden; Kevin McMahon; Brian C Smith; K Matthew Scaglione Journal: Chembiochem Date: 2022-02-03 Impact factor: 3.461
Authors: A Umano; K Fang; Z Qu; J B Scaglione; S Altinok; C J Treadway; E T Wick; E Paulakonis; C Karunanayake; S Chou; T M Bardakjian; P Gonzalez-Alegre; R C Page; J C Schisler; N G Brown; D Yan; K M Scaglione Journal: J Biol Chem Date: 2022-04-07 Impact factor: 5.486
Authors: Yasaman Pakdaman; Siren Berland; Helene J Bustad; Sigrid Erdal; Bryony A Thompson; Paul A James; Kjersti N Power; Ståle Ellingsen; Martin Krooni; Line I Berge; Adrienne Sexton; Laurence A Bindoff; Per M Knappskog; Stefan Johansson; Ingvild Aukrust Journal: Int J Mol Sci Date: 2021-05-30 Impact factor: 5.923